Ovarian cancer patients can benefit from personalised vaccine, adoptive T cell therapy: Study
Combining the personalised cancer vaccine with adoptive T cell therapy (ACT) can benefit patients with late-stage, drug-resistant ovarian cancer, a ...
Tag: adoptive T cell therapy: Study
